When was Terra Bioforge founded?

Terra Bioforge was founded in 2016 and raised its 1st funding round 7 years after it was founded.

Where is Terra Bioforge located?

Terra Bioforge is headquartered in Middleton, United States.

Who is the current CEO of Terra Bioforge?

David Mead of Terra Bioforge. They have also founded 1 company.

Is Terra Bioforge a funded company?

Terra Bioforge is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jun 20, 2023.

When was the latest funding round of Terra Bioforge?

Terra Bioforge's latest funding was a $***** Seed round on Jun 20, 2023, with participation from 1 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $463M in funding in 2026 to date.

Where does Terra Bioforge rank among its competitors?

Terra Bioforge ranks 132nd amongst 147 active competitors, of which 70 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of Terra Bioforge?

Terra Bioforge's top competitors include Syngenta, Ginkgo Bioworks and Synthego. Among them, Antheia secured the most recent funding round in January, 2026.

Terra Bioforge - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of a synthetic biology platform for discovering microbial products. The platform integrates biosynthetic tools, including biosynthetic gene cluster cloning, refactoring, organism engineering, and data sciences for the discovery of natural products for a range of industries such as agriculture and pharmaceuticals, including antibiotics, antivirals, and anticancer therapeutics.

Website: terrabioforge.com
Social
Email ID: *****@terrabioforge.com
Phone Number: +1 **********

Key Metrics

Founded Year

2016

Location

Middleton, United States

Stage

Seed

Total Funding

$100K in 1 round

Latest Funding Round

Seed, Jun 20, 2023, $*****

Investors

Gener8tor

Ranked

132^nd among 147 active competitors

Similar Companies

Syngenta & 162 more

View Terra Bioforge's full profile

Terra Bioforge has raised a total funding of $100K over 1 round. Its latest funding round was a Seed round on Jun 20, 2023 for $*****. 1 investor participated in its latest round. Terra Bioforge has 1 institutional investor.

Here is the list of recent funding rounds of Terra Bioforge:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 20, 2023	7368836	Seed	4679515	6595388	9294276	6413942

Access funding benchmarks and valuations. Sign up today!

View details of Terra Bioforge's funding rounds and investors

The founders of Terra Bioforge are David Mead, Nancy Keller, Neil Kelleher and Mark Liles. David Mead is the CEO of Terra Bioforge.

Here are the details of Terra Bioforge's key team members:

David Mead: Co-Founder & CEO of Terra Bioforge and founder of 3 other companies, Terra Bioworks, Varigen Biosciences and Lucigen.
Contact Info: 1 email address
Nancy Keller: Co-Founder of Terra Bioforge.
Contact Info: 1 email address
Neil Kelleher: Co-Founder of Terra Bioforge.
Contact Info: 1 email address
Mark Liles: Co-Founder of Terra Bioforge.
Contact Info: 1 email address

View details of Terra Bioforge's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Terra Bioforge include Syngenta, Ginkgo Bioworks and Synthego. Here is the list of Top 10 competitors of Terra Bioforge, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Syngenta 2000, Basel (Switzerland), Acquired	Developer of technologies and sustainable farming practices for farmers	-	Analah Ventures, Europa	75/100
2nd	Ginkgo Bioworks 2008, Boston (United States), Public	Autonomous labs for biotechnology, empowering scientists to design the living world	$796M	Viking Global Investors, T. Rowe Price & 53 others	72/100
3rd	Synthego 2012, Redwood City (United States), Acquired	Developer of CRISPR-engineered cell and gene therapies	$460M	8VC, RA Capital Management & 30 others	71/100
4th	Twist Bioscience 2013, San Francisco (United States), Public	Developer of a semiconductor-based DNA synthesis platform	$321M	Fidelity Investments, Arch Venture Partners ... & 39 others	70/100
5th	AskBio 2001, Durham (United States), Acquired	Developer of AAV technologies for treating genetic and complex disorders	$235M	Vida Ventures, TPG & 4 others	68/100
6th	Amyris 2003, Emeryville (United States), Public	Developer of renewable products for industrial solutions	$487M	Temasek, Grupo Cornelio Brennand & 24 others	67/100
7th	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
8th	Think Bioscience 2019, Boulder (United States), Series A	Provider of synthetic biology platform to develop small-molecule therapeutics	$26M	Innovation Endeavors, Janus Henderson Investors ... & 12 others	65/100
9th	Checkerspot 2016, Oakland (United States), Series C	Novel materials for various applications using synthetic biology	$117M	ArrowMark Partners, Viking Global Investors ... & 15 others	65/100
10th	Asimov 2017, Boston (United States), Series B	Provider of integrated suite for advanced genetic design and manufacturing	$209M	Andreessen Horowitz, CPP Investments & 11 others	64/100
132nd	Terra Bioforge 2016, Middleton (United States), Seed	Provider of a synthetic biology platform for discovering microbial products	$100K	Gener8tor	23/100